Altshuler Shaham’s Galmed Pharmaceuticals GLMD Stock Holding History

Altshuler Shaham’s Portfolio GLMD Stock Details GLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-24	Closed	-$14K	–	268
2018 Q2	$14K	Buy	+24	New	+$34.7K	﹤0.01%	143

Other funds holding GLMD

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Altshuler Shaham's GLMD Position: Q3 2018 in Review

Altshuler Shaham sold out of Galmed Pharmaceuticals (GLMD) in Q3 2018, closing a stake of 24 shares — an estimated $14K sold.

Altshuler Shaham first reported a position in GLMD in Q2 2018 and held it in 1 quarter. The position peaked at $14K in Q2 2018. 38 funds tracked by Wall St. Rank hold GLMD as of Q3 2018.

Altshuler Shaham reported no remaining Galmed Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Altshuler Shaham sold 24 Galmed Pharmaceuticals shares in Q3 2018, an estimated $14K.
Altshuler Shaham first reported a position in Galmed Pharmaceuticals in Q2 2018 and held it in 1 quarter.
Altshuler Shaham's Galmed Pharmaceuticals position peaked at $14K in Q2 2018.
38 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q3 2018.

Based on Altshuler Shaham's 13F filing for Q3 2018, filed 13 Nov 2018.